BioScrip, Inc. (Nasdaq: BIOS) announced today that it will release its
second quarter 2009 financial results before the market opens on
Thursday, July 30th, and host a conference call shortly thereafter at
9:00 AM (Eastern Time) to discuss the results. Richard H. Friedman,
Chairman and Chief Executive Officer, Stanley G. Rosenbaum, Executive
Vice President and Chief Financial Officer, and Richard M. Smith,
President and Chief Operating Officer, will host the call.
Interested parties may participate in the conference call by dialing
800-768-5109 (US), or 212-231-2906 (International), 5-10 minutes prior
to the start of the call. A replay of the conference call will be
available from 12:00 p.m. Eastern Time on Thursday, July 30, through
12:00 p.m. Eastern Time on August 13, by dialing 800-633-8284 (US), or
402-977-9140 (International), and entering reservation #21431976. An
audio web cast and archive of the conference call will also be available
under the investor relations section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. is a specialty pharmaceutical healthcare organization
that partners with patients, physicians, healthcare payors and
pharmaceutical manufacturers to provide access to medications and
management solutions to optimize outcomes for chronic and other complex
healthcare conditions.
Forward Looking Statements
This press release may contain statements which constitute forward
looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, including statements regarding the
intent, belief or current expectations of the Company, its directors, or
its officers with respect to the future operating performance of the
Company and our success with respect to the integration and
consolidation. Investors are cautioned that any such forward looking
statements are not guarantees of future performance and involve risks
and uncertainties, and that actual results may differ materially from
those in the forward looking statements as a result of various factors.
Important factors that could cause such differences are described in the
Company's periodic filings with the Securities and Exchange Commission.
In-Site Communications, Inc.
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com
or
BioScrip,
Inc.
Stanley G. Rosenbaum, 952-979-3768
EVP, Chief Financial
Officer
srosenbaum@bioscrip.com
